MDMA-Assisted Therapy
Structured therapeutic support for complex PTSD and trauma.
In clinical trials
See if MDMA fits. Free assessmentMDMA-assisted therapy is a structured therapeutic approach combining MDMA with intensive psychotherapy sessions to process trauma, particularly PTSD. Phase 3 trials run by MAPS and its sponsor Lykos Therapeutics reported response rates significantly exceeding conventional PTSD treatments.
MDMA-assisted therapy is not currently FDA-approved. In August 2024, the FDA declined Lykos Therapeutics' application and asked for additional Phase 3 research, which is underway. In the meantime, many trauma therapists offer MDMA-informed preparation and integration support as a legal complement to clinical-trial participation or to experiences obtained in legal jurisdictions. Navii connects patients with clinicians trained in these approaches who work within current legal frameworks.
Who it's for
Complex PTSD, trauma survivors, veterans, first responders, and individuals for whom conventional trauma therapy has produced limited results.
Common questions
Is MDMA-assisted therapy legal?+
MDMA is not FDA-approved as a treatment. The FDA declined Lykos Therapeutics' 2024 application and additional Phase 3 trials are underway. Trained clinicians can legally provide preparation and integration therapy and, where available, clinical-trial pathways.
Who is MDMA-assisted therapy designed for?+
It's primarily studied for PTSD and complex trauma, particularly cases that haven't responded to conventional trauma therapy or medication.
Other treatments
Ketamine
Rapid relief for treatment-resistant depression, PTSD, and anxiety.
Psilocybin
Guided psilocybin sessions in legal Oregon and Colorado service centers.
TMS
FDA-cleared, non-invasive treatment for depression, OCD, and anxious depression.
IOP / PHP
Structured, multi-day-per-week care without a residential stay.
Residential
24/7 structured care in an immersive therapeutic environment.
Trauma intensive
Multi-day deep-dive trauma work with a specialist therapist.